Academic Bibliography

Search 200 years of publications by Ghent University researchers.

prof. dr. Tom Coenye

Faculty of Pharmaceutical Sciences > Department of Pharmaceutical analysis

Work address: Ottergemsesteenweg 460
9000 Gent
Email: Tom.Coenye@UGent.be
ORCID iD: 0000-0002-6407-0601

Show Sort by

Add to list
- Journal Article
- A1
- open access
Adaptation of Pseudomonas aeruginosa biofilms to tobramycin and the quorum sensing inhibitor C-30 during experimental evolution requires multiple genotypic and phenotypic changes

Mona Bové (UGent) , Mette Kolpen, Mads Lichtenberg, Thomas Bjarnsholt and Tom Coenye (UGent)

(2023) MICROBIOLOGY. 169(1).
Add to list
- Journal Article
- A2
- open access
High throughput determination of the biofilm prevention concentration for Pseudomonas aeruginosa biofilms using a synthetic cystic fibrosis sputum medium

Amber De Bleeckere (UGent) , Sara Van den Bossche (UGent) , Pieter-Jan De Sutter (UGent) , Tine Beirens, Aurélie Crabbé (UGent) and Tom Coenye (UGent)

(2023) BIOFILM. 5.
Add to list
- Journal Article
- A1
- open access
New concepts in antimicrobial resistance in cystic fibrosis respiratory infections

Pavel Drevinek, Rafael Canton, Helle Krogh Johansen, Lucas Hoffman, Tom Coenye (UGent) , Pierre-Regis Burgel and Jane C Davies

(2022) JOURNAL OF CYSTIC FIBROSIS. 21(6). p.937-945
Add to list
- Journal Article
- A1
- open access
Pellicle biofilm formation in Burkholderia cenocepacia J2315 is epigenetically regulated through WspH, a hybrid two-component system kinase-response regulator

Andrea Sass (UGent) , Ian Vandenbussche, Barbara Bellich, Paola Cescutti and Tom Coenye (UGent)

(2022) JOURNAL OF BACTERIOLOGY. 204(5).
Add to list
The anti-virulence activity of the non- mevalonate pathway inhibitor FR900098 towards Burkholderia cenocepacia is maintained during experimental evolution

Mona Bové (UGent) and Tom Coenye (UGent)

(2022) MICROBIOLOGY-SGM. 168(3).
Add to list
- Journal Article
- A1
- open access
The combination of diethyldithiocarbamate and copper ions is active against Staphylococcus aureus and Staphylococcus epidermidis biofilms in vitro and in vivo

Laurine Kaul, Adrian I. Abdo, Tom Coenye (UGent) , Bastiaan P. Krom, Michel A. Hoogenkamp, Andrew C. W. Zannettino, Regine Suess and Katharina Richter

(2022) FRONTIERS IN MICROBIOLOGY. 13.
Add to list
- Journal Article
- A1
- open access
Phenotypic characterization and heterogeneity among modern clinical isolates of Acinetobacter baumannii

Adam Valcek, Chantal Philippe, Clemence Whiteway, Etienne Robino, Kristina Nesporova, Mona Bové (UGent) , Tom Coenye (UGent) , Tim De Pooter, Wouter De Coster, Mojca Strazisar, et al.

(2022) MICROBIOLOGY SPECTRUM. 11(11).
Add to list
- Journal Article
- A1
- open access
Biofilm antimicrobial susceptibility through an experimental evolutionary lens

Tom Coenye (UGent) , Mona Bové (UGent) and Thomas Bjarnsholt

(2022) NPJ BIOFILMS AND MICROBIOMES. 8(1).
Add to list
- Journal Article
- A1
- open access
Sebaceous immunobiology-skin homeostasis, pathophysiology, coordination of innate immunity and inflammatory response and disease associations

Christos C. Zouboulis, Tom Coenye (UGent) , Li He, Kenji Kabashima, Tetsuro Kobayashi, Catherin Niemann, Takashi Nomura, Attila Olah, Mauro Picardo, Sven R. Quist, et al.

(2022) FRONTIERS IN IMMUNOLOGY. 13.
Add to list
- Journal Article
- A1
- open access
Antibiofilm activities of borneol-citral-loaded pickering emulsions against Pseudomonas aeruginosa and Staphylococcus aureus in physiologically relevant chronic infection models

Wen Wang (UGent) , Xuerui Bao (UGent) , Mona Bové (UGent) , Petra Rigole (UGent) , Xiaofeng Meng, Jianyu Su and Tom Coenye (UGent)

(2022) MICROBIOLOGY SPECTRUM. 10(5).

1
2
3
4
…
36
37

Next →